Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Bosutinib in Adult Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Metronomic Temozolamide in Patients With Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Dendritic Cell Vaccination for Patients with Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Memantine for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide in Elderly Patients With KPS < 70
- Status
- COMPLETED
- Phase
- PHASE2
Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
- Status
- UNKNOWN
- Phase
- N/A
Dendritic Cell Vaccine for Patients With Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
SCH-900105 in Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2